Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,365
Closed -$339K 7946
2025
Q3
$339K Buy
23,365
+16,902
+262% +$172K ﹤0.01% 3751
2025
Q2
$63.5K Buy
6,463
+1,330
+26% +$11K ﹤0.01% 4871
2025
Q1
$37.3K Sell
5,133
-735
-13% -$6.43K ﹤0.01% 4920
2024
Q4
$45.9K Buy
5,868
+818
+16% +$6.74K ﹤0.01% 4774
2024
Q3
$37.4K Sell
5,050
-63
-1% -$530 ﹤0.01% 4951
2024
Q2
$41K Sell
5,113
-7,787
-60% -$69.5K ﹤0.01% 4832
2024
Q1
$150K Buy
12,900
+972
+8% +$10.8K ﹤0.01% 3922
2023
Q4
$133K Sell
11,928
-7,768
-39% -$71.4K ﹤0.01% 4223
2023
Q3
$304K Sell
19,696
-6,931
-26% -$116K ﹤0.01% 3675
2023
Q2
$505K Buy
26,627
+23,694
+808% +$416K ﹤0.01% 3148
2023
Q1
$44.7K Buy
2,933
+1,351
+85% +$17.6K ﹤0.01% 5027
2022
Q4
$21K Buy
1,582
+400
+34% +$3.6K ﹤0.01% 5529
2022
Q3
$7K Buy
1,182
+900
+319% +$3.95K ﹤0.01% 6181
2022
Q2
$1K Buy
+282
New +$851 ﹤0.01% 7067

Other funds holding ETNB

Osaic Holdings's ETNB Position: Q4 2025 in Review

Osaic Holdings sold out of 89bio (ETNB) in Q4 2025, closing a stake of 23,365 shares — an estimated $339K sold.

Osaic Holdings first reported a position in ETNB in Q2 2022 and held it in 14 quarters. The position peaked at $505K in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Osaic Holdings reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 23,365 89bio shares in Q4 2025, an estimated $339K.
  • Osaic Holdings first reported a position in 89bio in Q2 2022 and held it in 14 quarters.
  • Osaic Holdings's 89bio position peaked at $505K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.